An Non-Interventional Study of Patients With Persistent Symptoms of Schizophrenia
NCT ID: NCT01634542
Last Updated: 2016-11-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1433 participants
OBSERVATIONAL
2011-02-28
2014-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cohort
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Adult patients, \>/= 18 years of age
* Diagnosis of schizophrenia according to Diagnostic and Statistical Manual for Mental Disorders, 4th Edition, Text Revision (DSM-IV-TR) or International Classification of Diseases, 10th revision (ICD-10)
Caregivers:
* Age \>/= 18 years
* Family member or friend of the patient, who spends at least 4 hours a week with the patient
Exclusion Criteria
* Enrolled in an interventional study at the baseline observation
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hoffmann-La Roche
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Clinical Trials
Role: STUDY_DIRECTOR
Hoffmann-La Roche
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Buenos Aires, , Argentina
Caba, , Argentina
La Plata, , Argentina
Goiânia, Goiás, Brazil
Curitiba, Paraná, Brazil
São Paulo, São Paulo, Brazil
São Paulo, São Paulo, Brazil
Medicine Hat, Alberta, Canada
Vancouver, British Columbia, Canada
Chatam, Ontario, Canada
Mississauga, Ontario, Canada
Windsor, Ontario, Canada
Montreal, Quebec, Canada
Montreal, Quebec, Canada
Québec, Quebec, Canada
Verdun, Quebec, Canada
Aix-en-Provence, , France
Chaumont, , France
Colmar, , France
Corbeil-Essonnes, , France
Issy-les-Moulineaux, , France
Lille, , France
Lyon, , France
Marseille, , France
Marseille, , France
Marseille, , France
Marseille, , France
Montberon, , France
Montebeliard, , France
Montpellier, , France
Nantes, , France
Nice, , France
Nice, , France
Paris, , France
Paris, , France
Paris, , France
Poitiers, , France
Rennes, , France
Rouffach, , France
Saint-Cyr-au-Mont-d'Or, , France
Tassin-la-Demi-Lune, , France
Toulouse, , France
Verdun, , France
Aachen, , Germany
Aachen, , Germany
Alzey, , Germany
Augsburg, , Germany
Bad Zwischenahn, , Germany
Berlin, , Germany
Berlin, , Germany
Berlin, , Germany
Berlin, , Germany
Bochum, , Germany
Cologne, , Germany
Dortmund, , Germany
Dresden, , Germany
Düsseldorf, , Germany
Ellwangen, , Germany
Essen, , Germany
Essen, , Germany
Grünstadt, , Germany
Halle, , Germany
Hamburg, , Germany
Hamburg, , Germany
Hamburg, , Germany
Hamburg, , Germany
Homburg/Saar, , Germany
Jena, , Germany
Koeln-Pulheim, , Germany
Leipzig, , Germany
Leipzig, , Germany
Magdeburg, , Germany
Mainz, , Germany
Mannheim, , Germany
Marburg, , Germany
Mittweida, , Germany
Oranienburg, , Germany
Regensburg, , Germany
Rostock, , Germany
Siegen, , Germany
Weinsberg, , Germany
Westerstede, , Germany
Bari, Apulia, Italy
Catanzaro, Calabria, Italy
Bologna, Emilia-Romagna, Italy
Trieste, Friuli Venezia Giulia, Italy
Udine, Friuli Venezia Giulia, Italy
Rome, Lazio, Italy
Rome, Lazio, Italy
Rome, Lazio, Italy
Genoa, Liguria, Italy
Cassina Nuova Di Bollate, Lombardy, Italy
Gardone V.T., Lombardy, Italy
Milan, Lombardy, Italy
Milan, Lombardy, Italy
Milan, Lombardy, Italy
Campobasso, Molise, Italy
Bra, Piedmont, Italy
Novara, Piedmont, Italy
Cagliari, Sardinia, Italy
Sassari, Sardinia, Italy
Catania, Sicily, Italy
Messina, Sicily, Italy
Palermo, Sicily, Italy
Florence, Tuscany, Italy
Perugia, Umbria, Italy
Conegliano, Veneto, Italy
Padua, Veneto, Italy
Alcoy, Alicante, Spain
Almería, Almeria, Spain
Manacor, Balearic Islands, Spain
Palma de Mallorca, Balearic Islands, Spain
Barcelona, Barcelona, Spain
Barcelona, Barcelona, Spain
Terrassa, Barcelona, Spain
Burgos, Burgos, Spain
Santander, Cantabria, Spain
Torrelavega, Cantabria, Spain
Granada, Granada, Spain
A Coruña, La Coruña, Spain
Málaga, Malaga, Spain
Pamploma, Navarre, Spain
Pamplona, Navarre, Spain
Palencia, Palencia, Spain
Vigo, Pontevedra, Spain
Langreo, Principality of Asturias, Spain
Soria, Soria, Spain
Reus, Tarragona, Spain
Valencia, Valencia, Spain
Valladolid, Valladolid, Spain
Bilbao, Vizcaya, Spain
Bilbao, Vizcaya, Spain
Vitoria-Gasteiz, Vizcaya, Spain
Belfast, , United Kingdom
Bristol, , United Kingdom
Cambridge, , United Kingdom
Cheshire, , United Kingdom
Cornwall, , United Kingdom
Coventry, , United Kingdom
Essex, , United Kingdom
Glasgow, , United Kingdom
Hemel Hempstead, , United Kingdom
Lincolnshire, , United Kingdom
Norfolk, , United Kingdom
Nottingham, , United Kingdom
Stoke-on-Trent, , United Kingdom
Walsall, , United Kingdom
Wolverhampton, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Domenech C, Pastore A, Altamura AC, Bernasconi C, Corral R, Elkis H, Evans J, Malla A, Margari F, Krebs MO, Nordstroem AL, Zink M, Haro JM. Correlation of Health-Related Quality of Life in Clinically Stable Outpatients with Schizophrenia. Neuropsychiatr Dis Treat. 2019 Dec 20;15:3475-3486. doi: 10.2147/NDT.S218578. eCollection 2019.
Franklin M, Mukuria C, Mulhern B, Tran I, Brazier J, Watson S. Measuring the Burden of Schizophrenia Using Clinician and Patient-Reported Measures: An Exploratory Analysis of Construct Validity. Patient. 2019 Aug;12(4):405-417. doi: 10.1007/s40271-019-00358-x.
Domenech C, Bernasconi C, Moneta MV, Nordstroem AL, Cristobal-Narvaez P, Vorstenbosch E, Cobo J, Ochoa S, Haro JM. Health-related quality of life associated with different symptoms in women and in men who suffer from schizophrenia. Arch Womens Ment Health. 2019 Jun;22(3):357-365. doi: 10.1007/s00737-018-0896-0. Epub 2018 Aug 7.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MN28151
Identifier Type: -
Identifier Source: org_study_id